Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1985 Nov;82(21):7265–7269. doi: 10.1073/pnas.82.21.7265

Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100.

C F Wei, S H Chen, C Y Yang, Y L Marcel, R W Milne, W H Li, J T Sparrow, A M Gotto Jr, L Chan
PMCID: PMC390830  PMID: 2932736

Abstract

Apolipoprotein (apo) B-100 cDNAs were identified in a human liver cDNA library cloned in the expression vector lambda gt11. The beta-galactosidase-apoB-100 fusion protein was detected by two independently produced low density lipoprotein polyclonal antisera and by three apoB-100 monoclonal antibodies that crossreact with apoB-74. It was not recognized by two apoB-100 monoclonal antibodies that crossreact with apoB-26. The longest clone, lambda B8, was completely sequenced. It contains a 2.8-kilobase DNA fragment containing the codons for the carboxyl-terminal 836 amino acid residues of apo-B-100, as well as the 3' untranslated region of apoB-100 mRNA. We have thus mapped apoB-74 to the carboxyl-terminal portion of apoB-100. The deduced amino acid sequence of the cloned DNA matches the sequences of 14 apoB-100 peptides determined in our laboratory. Minor differences in amino acid sequence were noted in three of the peptides, suggesting polymorphism of apoB-100 at the protein and DNA levels. Secondary structure predictions reveal an unusual pattern for apolipoproteins, consisting of beta-structure (24%), alpha-helical content (33%), and random structure (30%). Ten amphipathic helical regions of 10-24 residues were identified. This carboxyl-terminal fragment of apoB-100 is considerably more hydrophobic than other apolipoproteins with known structure. Its lipid binding regions might include stretches of highly hydrophobic beta-sheets as well as amphipathic helices. Our findings on apoB structure might be important for understanding the role of apoB-100-containing lipoproteins in atherosclerosis.

Full text

PDF
7265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLUMBERG B. S., DRAY S., ROBINSON J. C. Antigen polymorphism of a low-density beta-lipoprotein. Allotypy in human serum. Nature. 1962 May 19;194:656–658. doi: 10.1038/194656a0. [DOI] [PubMed] [Google Scholar]
  2. Bradley W. A., Rohde M. F., Gotto A. M., Jr, Jackson R. L. The cyanogen bromide peptides of the apoprotein of low density lipoprotein (ApoB): its molecular weight from a chemical view. Biochem Biophys Res Commun. 1978 Apr 14;81(3):928–935. doi: 10.1016/0006-291x(78)91440-7. [DOI] [PubMed] [Google Scholar]
  3. Brown M. S., Goldstein J. L. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts. Cell. 1975 Nov;6(3):307–316. doi: 10.1016/0092-8674(75)90182-8. [DOI] [PubMed] [Google Scholar]
  4. Cardin A. D., Witt K. R., Barnhart C. L., Jackson R. L. Sulfhydryl chemistry and solubility properties of human plasma apolipoprotein B. Biochemistry. 1982 Aug 31;21(18):4503–4511. doi: 10.1021/bi00261a048. [DOI] [PubMed] [Google Scholar]
  5. Chen G. C., Kane J. P. Temperature dependence of the optical activity of human serum low density lipoprotein. The role of lipids. Biochemistry. 1975 Jul 29;14(15):3357–3362. doi: 10.1021/bi00686a011. [DOI] [PubMed] [Google Scholar]
  6. Chou P. Y., Fasman G. D. Empirical predictions of protein conformation. Annu Rev Biochem. 1978;47:251–276. doi: 10.1146/annurev.bi.47.070178.001343. [DOI] [PubMed] [Google Scholar]
  7. Deutsch D. G., Heinrikson R. L., Foreman J., Scanu A. M. Studies of the cyanogen bromide fragments of the apoprotein of human serum low density lipoproteins. Biochim Biophys Acta. 1978 May 25;529(2):342–350. doi: 10.1016/0005-2760(78)90077-2. [DOI] [PubMed] [Google Scholar]
  8. Eisenberg D., Weiss R. M., Terwilliger T. C. The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature. 1982 Sep 23;299(5881):371–374. doi: 10.1038/299371a0. [DOI] [PubMed] [Google Scholar]
  9. Goldstein J. L., Brown M. S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897–930. doi: 10.1146/annurev.bi.46.070177.004341. [DOI] [PubMed] [Google Scholar]
  10. Gotto A. M., Levy R. I., Fredrickson D. S. Observations on the conformation of human beta lipoprotein: evidence for the occurrence of beta structure. Proc Natl Acad Sci U S A. 1968 Aug;60(4):1436–1441. doi: 10.1073/pnas.60.4.1436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hewick R. M., Hunkapiller M. W., Hood L. E., Dreyer W. J. A gas-liquid solid phase peptide and protein sequenator. J Biol Chem. 1981 Aug 10;256(15):7990–7997. [PubMed] [Google Scholar]
  12. Kane J. P. Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol. 1983;45:637–650. doi: 10.1146/annurev.ph.45.030183.003225. [DOI] [PubMed] [Google Scholar]
  13. Kane J. P., Hardman D. A., Paulus H. E. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci U S A. 1980 May;77(5):2465–2469. doi: 10.1073/pnas.77.5.2465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982 May 5;157(1):105–132. doi: 10.1016/0022-2836(82)90515-0. [DOI] [PubMed] [Google Scholar]
  15. Lee D. M., Valente A. J., Kuo W. H., Maeda H. Properties of apolipoprotein B in urea and in aqueous buffers. The use of glutathione and nitrogen in its solubilization. Biochim Biophys Acta. 1981 Oct 23;666(1):133–146. doi: 10.1016/0005-2760(81)90099-0. [DOI] [PubMed] [Google Scholar]
  16. Malloy M. J., Kane J. P., Hardman D. A., Hamilton R. L., Dalal K. B. Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein. J Clin Invest. 1981 May;67(5):1441–1450. doi: 10.1172/JCI110173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Marcel Y. L., Hogue M., Theolis R., Jr, Milne R. W. Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against low density lipoproteins. J Biol Chem. 1982 Nov 25;257(22):13165–13168. [PubMed] [Google Scholar]
  18. Marcel Y. L., Hogue M., Weech P. K., Milne R. W. Characterization of antigenic determinants on human solubilized apolipoprotein B. Conformational requirements for lipids. J Biol Chem. 1984 Jun 10;259(11):6952–6957. [PubMed] [Google Scholar]
  19. Milne R. W., Theolis R., Jr, Verdery R. B., Marcel Y. L. Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis. 1983 Jan-Feb;3(1):23–30. doi: 10.1161/01.atv.3.1.23. [DOI] [PubMed] [Google Scholar]
  20. Morrisett J. D., Jackson R. L., Gotto A. M., Jr Lipoproteins: structure and function. Annu Rev Biochem. 1975;44:183–207. doi: 10.1146/annurev.bi.44.070175.001151. [DOI] [PubMed] [Google Scholar]
  21. Patsch J. R., Sailer S., Kostner G., Sandhofer F., Holasek A., Braunsteiner H. Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation. J Lipid Res. 1974 Jul;15(4):356–366. [PubMed] [Google Scholar]
  22. Rash J. M., Rothblat G. H., Sparks C. E. Lipoprotein apolipoprotein synthesis by human hepatoma cells in culture. Biochim Biophys Acta. 1981 Nov 23;666(2):294–298. doi: 10.1016/0005-2760(81)90120-x. [DOI] [PubMed] [Google Scholar]
  23. Sanger F., Coulson A. R., Barrell B. G., Smith A. J., Roe B. A. Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol. 1980 Oct 25;143(2):161–178. doi: 10.1016/0022-2836(80)90196-5. [DOI] [PubMed] [Google Scholar]
  24. Schumaker V. N., Robinson M. T., Curtiss L. K., Butler R., Sparkes R. S. Anti-apoprotein B monoclonal antibodies detect human low density lipoprotein polymorphism. J Biol Chem. 1984 May 25;259(10):6423–6430. [PubMed] [Google Scholar]
  25. Segrest J. P., Jackson R. L., Morrisett J. D., Gotto A. M., Jr A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett. 1974 Jan 15;38(3):247–258. doi: 10.1016/0014-5793(74)80064-5. [DOI] [PubMed] [Google Scholar]
  26. Shulman M., Wilde C. D., Köhler G. A better cell line for making hybridomas secreting specific antibodies. Nature. 1978 Nov 16;276(5685):269–270. doi: 10.1038/276269a0. [DOI] [PubMed] [Google Scholar]
  27. Steele J. C., Jr, Reynolds J. A. Molecular weight and hydrodynamic properties of apolipoprotein B in guanidine hydrochloride and sodium dodecyl sulfate solutions. J Biol Chem. 1979 Mar 10;254(5):1639–1643. [PubMed] [Google Scholar]
  28. Theolis R., Jr, Weech P. K., Marcel Y. L., Milne R. W. Characterization of antigenic determinants of human apolipoprotein B. Distribution on tryptic fragments of low density lipoprotein. Arteriosclerosis. 1984 Sep-Oct;4(5):498–509. doi: 10.1161/01.atv.4.5.498. [DOI] [PubMed] [Google Scholar]
  29. Yang C. Y., Pownall H. J., Gotto A. M., Jr Identification of peptides containing tryptophan, tyrosine, and phenylalanine using photodiode-array spectrophotometry. Anal Biochem. 1985 Feb 15;145(1):67–72. doi: 10.1016/0003-2697(85)90327-6. [DOI] [PubMed] [Google Scholar]
  30. Young R. A., Davis R. W. Efficient isolation of genes by using antibody probes. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1194–1198. doi: 10.1073/pnas.80.5.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Young R. A., Davis R. W. Yeast RNA polymerase II genes: isolation with antibody probes. Science. 1983 Nov 18;222(4625):778–782. doi: 10.1126/science.6356359. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES